J. Engel

J. Siewert, K. Jauch, J. Engel, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

A. Gavin, H. Comber, M. Rugge, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients

N. Harbeck, N. Ditsch, A. Farr, 2018, Breast Care.

The surgical discharge summary: a lack of substantial clinical information may affect the postop treatment of rectal cancer patients

D. Hölzel, K. Jauch, J. Engel, 2001, Langenbeck's Archives of Surgery.

Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry.

C. Stief, C. Gratzke, J. Engel, 2014, European urology.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

N. Girard, A. Gavin, H. Comber, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas: A Summary of 480 Cases

R. Langer, H. Friess, K. Becker, 2011, Annals of surgery.

Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer

V. Heinemann, T. Schiergens, J. Neumann, 2020, Virchows Archiv.

Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma

H. Friess, J. Werner, A. Agha, 2018, Strahlentherapie und Onkologie.

pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas—proposal for a new pT3a/pT3b subclassification

W. Weichert, C. Denkert, I. Nagtegaal, 2022, British Journal of Cancer.

Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer

J. Werner, V. Heinemann, J. Mayerle, 2022, JNCI cancer spectrum.

The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer

J. Werner, V. Heinemann, S. Ormanns, 2022, International journal of cancer.

Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline.

S. Verma, R. Kandel, J. Werier, 2013, Current oncology.

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia

R. Schlenk, H. Döhner, J. Hasford, 2008, Haematologica.

Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis

C. Stief, C. Belka, S. Combs, 2017, Radiation Oncology.

BRCA1/2 mutation prevalence in triple-negative breast cancer patients without family history of breast and ovarian cancer.

D. Steinemann, A. Meindl, R. Schmutzler, 2016 .

Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma

H. Hermeking, A. Gerbes, F. Kolligs, 2010, Clinical Cancer Research.

Gender differences in melanoma survival: female patients have a decreased risk of metastasis.

J. Coebergh, A. Eggermont, T. Nijsten, 2011, The Journal of investigative dermatology.

Status of quality of life in breast cancer research before, during and beyond treatment

D. Ankerst, J. Engel, 2006, Expert review of pharmacoeconomics & outcomes research.

Level of hospital care and outcome of gastric cancer: a population-based evaluation of the Munich Cancer Registry

J. Kleeff, R. Emeny, K. Jauch, 2014, Journal of Cancer Research and Clinical Oncology.

THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients

N. Ditsch, U. Jeschke, C. Kuhn, 2019 .

2008 update of the guideline: early detection of breast cancer in Germany

R. Schulz-Wendtland, T. Kühn, R. Kreienberg, 2009, Journal of Cancer Research and Clinical Oncology.

Chromogenic in situ hybridization for Her‐2/neu‐oncogene in breast cancer: comparison of a new dual‐colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization

D. Mayr, J. Engel, T. Kirchner, 2009, Histopathology.

Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival

J. Kleeff, V. Heinemann, J. Holch, 2020, International journal of cancer.

Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients.

H. Sommer, K. Friese, J. Engel, 2010, Psychosomatics.

Predictors of Quality of Life of Breast Cancer Patients

J. Engel, J. Kerr, H. Sauer, 2003, Acta oncologica.

The process of metastasisation for breast cancer.

D Hölzel, H. Senn, J. Engel, 2003, European journal of cancer.

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.

A. Gavin, H. Comber, M. Rugge, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer

H. Hermeking, Markus Kaller, T. Schiergens, 2018, Clinical Cancer Research.

Changes in Prognostic and Therapeutic Parameters in Prostate Cancer from an Epidemiological View over 20 Years

J. Engel, D. Hölzel, G. Schubert‐Fritschle, 2015, Oncology Research and Treatment.

Colorectal Cancers Mimic Structural Organization of Normal Colonic Crypts

H. Hermeking, D. Horst, J. Engel, 2014, PloS one.

Toward the Prognostic Signi fi cance and Therapeutic Potential of HER 3 Receptor Tyrosine Kinase in Human Colon Cancer

A. Ullrich, D. Horst, J. Engel, 2012 .

Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer

A. Ullrich, D. Horst, J. Engel, 2011, Clinical Cancer Research.

Towards the prognostic significance and therapeutic potential of HER 3 receptor tyrosine kinase in human colon cancer

A. Ullrich, D. Horst, J. Engel, 2011 .

Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays.

G. Amann, U. Löhrs, J. Diebold, 2006, American journal of clinical pathology.

The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.

D. Horst, L. Kriegl, J. Engel, 2012, Experimental and molecular pathology.

γ-Catenin is an independent prognostic marker in early stage colorectal cancer

C. Mantzoros, S. Gautam, F. Kolligs, 2010, International Journal of Colorectal Disease.

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

R. Kimmig, J. Rehbock, J. Diebold, 2002, European journal of cancer.

Positive lymph nodes do not metastasize

R. Emeny, J. Engel, D. Hölzel, 2011, Cancer and Metastasis Reviews.

A simple immunohistochemical algorithm predicts the risk of distant metastases in right‐sided colon cancer

J. Neumann, D. Horst, L. Kriegl, 2012, Histopathology.

HER‐2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays

G. Amann, U. Löhrs, J. Diebold, 2006, Histopathology.

Quality of Life Following Breast‐Conserving Therapy or Mastectomy: Results of a 5‐Year Prospective Study

Jacqueline Kerr, Jutta Engel, Dieter Hölzel, 2004, The breast journal.

True local recurrences do not metastasize

R. Emeny, J. Engel, D. Hölzel, 2011, Cancer and Metastasis Reviews.

Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030

K. Strauch, V. Heinemann, C. Westphalen, 2016, Cancer medicine.

[Elective lymph node dissections--still a standard in cancer surgery?].

U. Löhrs, J. Engel, D. Hölzel, 2008, Zentralblatt fur Chirurgie.

Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer

Thomas Kirchner, Jutta Engel, D. Horst, 2009, Cancer investigation.

Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes

M. Kiechle, D. Mayr, J. Engel, 2017, Journal of Cancer Research and Clinical Oncology.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

D. Horst, L. Kriegl, J. Engel, 2009, European journal of cancer.

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

A. Meindl, R. Schmutzler, M. Kiechle, 2018, BMC Cancer.

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants

M. lenhard, U. Jeschke, D. Mayr, 2013, BMC Cancer.

Kurzfassung der aktualisierten Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2008

R. Schulz-Wendtland, R. Schulz-Wendtland, T. Kühn, 2008 .

RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer

D. Horst, J. Engel, T. Kirchner, 2019, Journal of Cancer.

Quality of Life in Rectal Cancer Patients: A Four-Year Prospective Study

J. Engel, J. Kerr, H. Sauer, 2003, Annals of surgery.

Age and Outcome in Gastrointestinal Cancers: A Population-Based Evaluation of Oesophageal, Gastric and Colorectal Cancer

H. Friess, J. Werner, J. Engel, 2017, Visceral Medicine.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

A. Gavin, H. Comber, M. Rugge, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Morphology Matters

H. Friess, W. Weichert, D. Saur, 2021, The American journal of surgical pathology.

Morphology Matters

H. Friess, W. Weichert, D. Saur, 2021, American Journal of Surgical Pathology.

Analysis of FoxP3+ T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers

S. Endres, D. Anz, D. Mayr, 2014, PloS one.

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients

N. Ditsch, U. Jeschke, C. Kuhn, 2020, Journal of Cancer Research and Clinical Oncology.

Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.

U. Treiber, J. Engel, D. Zaak, 2008, European journal of cancer.

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.

J. Utikal, C. Berking, A. Gesierich, 2017, European journal of cancer.

Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study

H. Friess, J. Werner, J. Mayerle, 2019, Gut.

Distant metastases do not metastasize

R. Emeny, J. Engel, D. Hölzel, 2010, Cancer and Metastasis Reviews.

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

D. Horst, L. Kriegl, J. Engel, 2008, British Journal of Cancer.

Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data

K. Halfter, J. Engel, D. Hölzel, 2020, Journal of Cancer Research and Clinical Oncology.

Role of Radical Prostatectomy in Clinically Non-Organ-Confined Prostate Cancer

C. Stief, C. Gratzke, J. Engel, 2014, Current Urology Reports.

Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.

M. Kiechle, J. Engel, C. Anthuber, 2019, Gynecologic oncology.

[Ten years of epidemiological cancer registration in Bavaria].

W. Caselmann, T. Opitz, U. Mäder, 2009, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

Survival of de novo stage IV breast cancer patients over three decades

M. Kiechle, N. Harbeck, I. Bauerfeind, 2016, Journal of Cancer Research and Clinical Oncology.

The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations

W. Weichert, A. Noske, B. Haller, 2020, Cancer Immunology, Immunotherapy.

Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data.

J. Engel, S. Schrodi, A. Tillack, 2015, European journal of cancer care.

Clinical Cancer esearch ing , Diagnosis , Prognosis ression , Cellular Distribution , and Prognostic Relevance R RAIL Receptors in Hepatocellular Carcinoma

H. Hermeking, A. Gerbes, F. Kolligs, 2010 .

Determinants and prognoses of locoregional and distant progression in breast cancer.

J. Engel, U. Aydemir, S. Aydemir, 2003, International journal of radiation oncology, biology, physics.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

Matching Study to Registry data: Maintaining Data Privacy in a Study on Family based Colorectal Cancer

Ulrich Mansmann, Jürgen Stausberg, Daniel Nasseh, 2014, MIE.

Lymph node infiltration, parallel metastasis and treatment success in breast cancer.

W. Weichert, R. Emeny, J. Engel, 2019, Breast.

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer

H. Hermeking, D. Horst, J. Engel, 2016, Oncotarget.

A semiparametric Bayesian proportional hazards model for interval censored data with frailty effects

Ulrich Mansmann, Volkmar Henschel, Jutta Engel, 2009, BMC medical research methodology.

Surgical management of ipsilateral breast tumor recurrence.

N. Harbeck, S. Kahlert, N. Ditsch, 2015, International journal of surgery.

The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer

V. Heinemann, J. Neumann, J. Engel, 2018, Virchows Archiv.

Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort

H. Friess, J. Werner, A. Agha, 2016, Journal of Cancer Research and Clinical Oncology.

Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysis

M. Kiechle, D. Mayr, J. Engel, 2016, Journal of Cancer Research and Clinical Oncology.

Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.

N. Harbeck, I. Bauerfeind, J. Engel, 2015, Breast.

Hormone replacement therapy and elevated breast cancer risk: An artifact of growth acceleration?

J. Engel, D. Hölzel, G. Schubert‐Fritschle, 2020, medRxiv.

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

M. Kiechle, N. Harbeck, I. Bauerfeind, 2017, Journal of Cancer Research and Clinical Oncology.

Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer

N. Harbeck, S. Kahlert, J. Engel, 2016, Breast Care.

Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery

Marcus Schmidt, T. Reimer, B. Offersen, 2018, Breast Care.

Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.

M. Rezai, P. Fasching, A. Schneeweiss, 2021, European journal of cancer.

Epidemiology of Prostate Cancer

E. Wallen, R. Pruthi, J. Engel, 2013 .

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants

M. lenhard, U. Jeschke, D. Mayr, 2013, BMC Cancer.

Predictive value of early serum β‐hCG levels after single blastocyst transfer

J. Engel, C. Thaler, V. von Schönfeldt, 2009, Acta obstetricia et gynecologica Scandinavica.

Improved survival after resection of colorectal liver metastases in patients with unresectable lung metastases.

J. Werner, M. Guba, T. Schiergens, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system.

V. Heinemann, J. Neumann, J. Engel, 2015, Pathology, research and practice.

The Prognostic Value of Lymph Node Ratio in a Population-Based Collective of Colorectal Cancer Patients

H. Friess, T. Schuster, R. Rosenberg, 2010, Annals of surgery.

Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection.

A. Lebeau, J. Engel, H. Sauer, 2006, Breast.

Risk of contralateral second primary breast cancer according to hormone receptor status in Germany

A. Stang, C. Stegmaier, B. Holleczek, 2014, Breast Cancer Research.

The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany.

Bernhard Gibis, Uwe Siebert, Christa Stegmaier, 2006, European journal of public health.

TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer

V. Heinemann, M. von Bergwelt-Baildon, J. Engel, 2023, British Journal of Cancer.

[Recommendations on contents of medical reports in rectal carcinoma: I: Surgical report and pathology findings. Orientating aids in interdisciplinary management].

G. Anker, K. Jauch, J. Engel, 1998, Zentralblatt fur Chirurgie.

Survival for rectal cancer patients and international comparisons.

J. Engel, J. Kerr, D. Hölzel, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Improvement of Survival in Sex Cord Stromal Tumors: An Observational Study With More Than 25 Years Follow-Up

G. Bastert, H. Sommer, S. Sinz, 2009 .

The intratumoral distribution of nuclear β‐catenin is a prognostic marker in colon cancer

S. Reu, D. Horst, L. Kriegl, 2009, Cancer.

Reply from Authors re: Urs E. Studer, Laurence Collette, Richard Sylvester. Can Radical Prostatectomy Benefit Patients Despite the Presence of Regional Metastases? Eur Urol 2010;57:762-3

J. Gschwend, C. Stief, P. Bastian, 2010 .

Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

S. Rosso, V. Zadnik, H. Brenner, 2019, Archives of Gynecology and Obstetrics.

Synchronous colorectal liver metastases: focus on the elderly

J. Werner, M. Guba, T. Schiergens, 2017, Langenbeck's Archives of Surgery.

Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.

N. Harbeck, C. Belka, S. Corradini, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Population-Based Patient Care Study for Breast Cancer

J. Engel, H. Sauer, D. Hölzel, 1998, Oncology Research and Treatment.

Comparison of breast and rectal cancer patients' quality of life: results of a four year prospective field study.

J. Engel, J. Kerr, H. Sauer, 2003, European journal of cancer care.

No Survival Benefit for Patients with Treatment in Certified Breast Centers—A Population‐based Evaluation of German Cancer Registry Data

J. Engel, S. Schrodi, A. Tillack, 2015, The breast journal.

Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.

P. Hillemanns, U. Siebert, N. Mühlberger, 2011, European journal of cancer.

Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases

N. Harbeck, C. Belka, S. Corradini, 2018, Radiation oncology.

Population-based hormone receptor-specific incidence trends of breast cancer in Germany.

A. Stang, C. Stegmaier, O. Kuss, 2012, Maturitas.

Primary breast cancer therapy in six regions of Germany.

C. Meisner, G. Nagel, C. Mittermayer, 2002, European journal of cancer.

Is Tumor Dormancy Clinically Relevant

R. Emeny, J. Engel, D. Hölzel, 2013 .

Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients.

J. Engel, J. Kerr, H. Sauer, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Colonoscopy and polypectomy: beside age, size of polyps main factor for long-term risk of colorectal cancer in a screening population

K. Halfter, J. Engel, D. Hölzel, 2021, Journal of Cancer Research and Clinical Oncology.

Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis

C. Stief, C. Belka, S. Combs, 2017, Radiation oncology.

Use of cancer-specific mental health resources—is there an urban-rural divide?

J. Engel, A. Beraldi, P. Herschbach, 2014, Supportive Care in Cancer.

Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?

J. Werner, W. Thasler, Hao Feng, 2016, Journal of Gastrointestinal Surgery.

Adjuvant chemotherapy for breast cancer – prognostic impact of relative dose-intensity.

J. Rosenfeld, S. Kahlert, K. Friese, 2009 .

Doctor-Patient Communication: Results of a Four-Year Prospective Study in Rectal Cancer Patients

J. Engel, J. Kerr, H. Sauer, 2003, Diseases of the colon and rectum.

Her-2/neu and Topoisomerase II&agr; in Advanced Breast Cancer: A Comprehensive FISH Analysis of 245 Cases

S. Kahlert, J. Diebold, D. Mayr, 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival1

N. Harbeck, N. Ditsch, U. Jeschke, 2018, Translational oncology.

Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts

Stephanie E. Combs, Thomas Kirchner, Jutta Engel, 2017, Front. Oncol..

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

A. Meindl, R. Schmutzler, M. Kiechle, 2018, BMC Cancer.

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

U. Siebert, J. Engel, G. Sroczynski, 2023, BMC Cancer.

Kurzfassung der aktualisierten Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2008

R. Schulz-Wendtland, T. Kühn, R. Kreienberg, 2008, RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print).

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

C. Berking, A. Gesierich, M. Heppt, 2017, BMC Cancer.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

N. Girard, A. Gavin, H. Comber, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Doctor-Patient Communication

J. Engel, J. Kerr, H. Sauer, 2003, Diseases of the colon and rectum.

Positive lymph nodes do not metastasize

R. Emeny, J. Engel, D. Hölzel, 2011, Cancer and Metastasis Reviews.

Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study.

M. Kiechle, N. Harbeck, I. Bauerfeind, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.